Antiviral Treatments for coronavirus eligibility criteria

Patients must meet all the eligibility criteria and none of the exclusion criteria. Pre-hospitalised patients are eligible to be considered if:

  • SARS-CoV-2 infection is confirmed by polymerase chain reaction (PCR) testing within the last 72 hours OR
  • SARS-CoV-2 infection is confirmed by formally registered positive lateral flow testing (LFT) within the last 72 hours AND
  • Onset of symptoms of COVID-192 3 within the last 7 days

‘Highest’ risk group

The following patient cohorts were determined by an independent advisory group commissioned by the Department of Health and Social Care (DHSC)

  • Down’s syndrome and other genetic disorders
  • Sickle cell disease
  • Patients with a solid cancer
  • Patients with a haematologic malignancy
  • Patients with renal disease
  • Patients with liver disease
  • Patients with immune-mediated inflammatory disorders (IMID)
  • Primary immune deficiencies
  • Solid organ transplant recipients or Rare neurological conditions.



Local Services, Let